# FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

> clinical trial · VERIFIED · 2026-06-08

Status: RECRUITING · Sponsor: Oncolytics Biotech · Condition: Ras-mutated Metastatic Colorectal Cancer

- Company: Oncolytics Biotech
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07446322

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.